Ergoteles LLC Dexcom Inc Transaction History

Ergoteles LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $245,297 - $285,667	2,181 Added 35.42%	8,339 $1.07 Million
Q1 2023 May 10, 2023	SELL	$104.0 - $122.92 $12.5 Million - $14.8 Million	-120,423 Reduced 95.14%	6,158 $715,000
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $5.73 Million - $8.27 Million	67,410 Added 113.92%	126,581 $14.3 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $8.81 Million - $10.9 Million	-115,406 Reduced 66.11%	59,171 $4.77 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $11.8 Million - $23 Million	172,896 Added 10285.31%	174,577 $13 Million
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $59,646 - $82,546	634 Added 60.55%	1,681 $860,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $135,973 - $170,472	1,047 New	1,047 $562,000
Q1 2021 May 12, 2021	SELL	$84.79 - $104.74 $50,874 - $62,844	-600 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$78.0 - $104.5 $46,800 - $62,700	600 New	600 $222,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.